Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aminex Therapeutics Inc.
DescriptionCombination of a polyamine transport inhibitor and difluoromethylornithine, an ornithine decarboxylase inhibitor
Molecular Target Ornithine decarboxylase (ODC)
Mechanism of ActionOrnithine decarboxylase (ODC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today